Inventor · disambiguated record
Jing Pan
Also filed as: PAN JING
37 granted patents·26 pending applications·200 citations·filing 2004–2025
97Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES15ANP TECH INC11TAKEDA PHARMACEUTICALS CO7YIN RAY7ANP TECHNOLOGIES INC6
Top patents by PatentIndex Score
63 records- 0193US2025161417A1Methods and compositions for cns delivery of arylsulfatase aTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0293US2025121040A1Methods and compositions for cns delivery of iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0392US9220677B2Methods and compositions for CNS delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Dec 29, 2015·16 cites·27 claims
- 0492US8545837B2Methods and compositions for CNS delivery of iduronate-2-sulfataseZHU GAOZHONG·Filed 2011·Granted Oct 1, 2013·38 cites·30 claims
- 0592US2025375506A1Cns delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 0691US11065308B2Methods and compositions for CNS delivery of heparan n-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted Jul 20, 2021·6 cites·5 claims
- 0791US10456454B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Oct 29, 2019·6 cites·27 claims
- 0891US9283181B2CNS delivery of therapeutic agentsCALIAS PERICLES·Filed 2011·Granted Mar 15, 2016·34 cites·6 claims
- 0990US10660944B2Stable formulations for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted May 26, 2020·5 cites·23 claims
- 1089US11471516B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Oct 18, 2022·1 cites·17 claims
- 1189US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 1288US9944755B2Oxazoline polymer compositions and use thereofANP TECH INC·Filed 2016·Granted Apr 17, 2018·4 cites·17 claims
- 1386US11260112B2Methods and compositions for CNS delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Mar 1, 2022·2 cites·17 claims
- 1486US9320711B2Methods and compositions for CNS delivery of heparan N-sulfataseNATOLI FARAH·Filed 2011·Granted Apr 26, 2016·22 cites·43 claims
- 1585US12409210B2CNS delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 9, 2025·0 cites·5 claims
- 1683US11801230B2Nanoparticles containing a taxane and their useANP TECH INC·Filed 2021·Granted Oct 31, 2023·1 cites·19 claims
- 1783US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 1882US8563329B2Polymer conjugate enhanced bioassaysYIN RAY·Filed 2006·Granted Oct 22, 2013·7 cites·21 claims
- 1981US12121569B2Methods and compositions for CNS delivery of iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 22, 2024·0 cites·15 claims
- 2080US10688048B2Hydrophobic molecule-induced branched polymer aggregates and their useANP TECH INC·Filed 2017·Granted Jun 23, 2020·1 cites·16 claims
- 2180US10603364B2Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 31, 2020·2 cites·7 claims
- 2280US9770410B2Methods and compositions for CNS delivery of arylsulfatase ASALAMAT-MILLER NAZILA·Filed 2011·Granted Sep 26, 2017·10 cites·32 claims
- 2379US12161702B2Methods and compositions for CNS delivery of heparan N-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Dec 10, 2024·0 cites·19 claims
- 2477US9176142B2Polymer conjugate enhanced bioassaysANP TECHNOLOGIES INC·Filed 2013·Granted Nov 3, 2015·2 cites·20 claims
- 2576US8591904B2Asymmetrically branched polymer conjugates and microarray assaysYIN RAY·Filed 2010·Granted Nov 26, 2013·2 cites·12 claims
- 2675US12168041B2Methods and compositions for CNS delivery of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 2775US7754500B2Asymmetrically branched polymer conjugates and microarray assaysANP TECHNOLOGIES INC·Filed 2004·Granted Jul 13, 2010·10 cites·46 claims
- 2874US12396962B2Nanoparticles containing a taxane and their useFULGENT GENETICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·20 claims
- 2973US10646554B2Methods and compositions for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted May 12, 2020·0 cites·19 claims
- 3073US2025195443A1Polymer Nanoaggregate Pharmaceutical Composition and Use ThereofANP TECH INC·Filed 2023·Application pending·0 cites
- 3172US9329187B2Immunogenicity AssayANP TECHNOLOGIES INC·Filed 2015·Granted May 3, 2016·1 cites·19 claims
- 3272US2025339381A1Nanoparticles Containing a Taxane and their UseFULGENT GENETICS INC·Filed 2025·Application pending·0 cites
- 3371US9745309B2Method for preparing a sitagliptin intermediateZHEJIANG MED XINCHANG PHARM·Filed 2014·Granted Aug 29, 2017·2 cites·12 claims
- 3471US2025108106A1Nanoencapsulated pharmaceutical composition and use thereofFULGENT GENETICS INC·Filed 2024·Application pending·0 cites
- 3567US12042561B2Hydrophobic molecule-induced branched polymer aggregates and their useANP TECH INC·Filed 2020·Granted Jul 23, 2024·0 cites·8 claims
- 3667US2025197843A1Instrument and methods involving high-throughput screening and directed evolution of molecular functionsUNIV FLORIDA·Filed 2023·Application pending·0 cites
- 3764US2020188315A1Nanoparticles Containing a Taxane and Their UseANP TECH INC·Filed 2019·Application pending·0 cites
- 3863US2017042977A1Methods and compositions for cns delivery of heparan n-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Application pending·0 cites
- 3962USD672053SMulti-lateral flow assay strip carrier assemblyCHEN DE·Filed 2010·Granted Dec 4, 2012·16 cites·1 claims
- 4062US2016158324A1Methods and compositions for cns delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 4161US2020237883A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 4260US10274501B2Immunogenicity assayANP TECH INC·Filed 2016·Granted Apr 30, 2019·0 cites·20 claims
- 4359US2014377244A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2012·Application pending·0 cites
- 4458US2019015350A1Nanoparticles Containing a Taxane and their UseANP TECH INC·Filed 2018·Application pending·0 cites
- 4558US2016024252A1Oxazoline Polymer Compositions and Use ThereofYIN RAY·Filed 2012·Application pending·0 cites
- 4658US2017202971A1Oxazoline Polymer Compositions and Use ThereofANP TECH INC·Filed 2017·Application pending·0 cites
- 4757US9360477B2Polymer conjugate enhanced bioassaysANP TECHNOLOGIES INC·Filed 2015·Granted Jun 7, 2016·0 cites·20 claims
- 4856US2015018250A1Symmetrically Branched Polymer Conjugates and Microarray AssaysYIN RAY·Filed 2014·Application pending·0 cites
- 4955US2023408498A1Compositions and methods involving antibody constructsCZ BIOHUB SAN FRANCISCO LLC·Filed 2021·Application pending·0 cites
- 5053US8597653B2Asymmetrically branched polymer conjugates and microarray assaysYIN RAY·Filed 2010·Granted Dec 3, 2013·0 cites·16 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jing Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →